Clinical Trials Directory

Trials / Unknown

UnknownNCT03093727

Characterization of Pulmonary Langerhans Cell Histiocytosis

Functional and Genetical Characterization of Pulmonary Langerhans Cell Histiocytosis: Diagnostic and Therapeutical Implications.

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Very recent studies indicate that a high percentage of HCL, about 50%, have mutations in the B-RAF oncogene. The development of ultrasensitive methodologies capable of identifying these mutations in bronchoalveolar lavage will represent a significant advance in the diagnosis and treatment of these patients. An undetermined percentage of HCL does not present mutations in B-RAF. Consequently, the deep genetic analysis, through the use of techniques of massive sequencing, can favor the identification of new alterations that contribute to the development of the disease. We hypothesized that patients with HCL may present a different inflammatory state to healthy subjects or smokers, allowing us to identify new biomarkers.

Detailed description

The main objective of this study is to expand the genetic and pathophysiological knowledge of this disease. For this, the following points will be developed: * Identification of mutations in the B-RAF oncogene in Spanish patients with pulmonary LCHF. * Development of ultrasensitive genetic analysis methods capable of identifying mutations in B-RAF in bronchoalveolar lavage (BAL) samples. * To determine if patients with mutations in the B-RAF oncogene present distinct clinical, radiological and / or functional characteristics compared to those with absence of the mutation. * Characterization of the inflammatory profile of patients with HPCL.

Conditions

Timeline

Start date
2013-09-27
Primary completion
2022-09-01
Completion
2023-09-01
First posted
2017-03-28
Last updated
2020-08-18

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03093727. Inclusion in this directory is not an endorsement.